The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-8C Bendamustine for indolent Lymphoma,

Sun. Oct 14, 2018 1:50 PM - 2:50 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Masataka Okamoto (Fujita Health University School of Medicine Department of Hematology, Japan)

[OS3-8C-4] The effect of BR followed by Zevalin sequential therapy in relapsed or refractory indolent NHL/MCL

Yuki Takeuchi, Hirofumi Yokota, Shihomi Taniyama, Hitomi Sawa, Kanae Imai, Yuichiro Inagaki, Tomonori Kato, Masashi Sawa (Department of Hematology and Oncology, Anjo Kosei Hospital)

Abstract password authentication.
Password is written on a program and abstract book.

Password